COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1437: Articles 14361-14370  | Next

A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo
Chiem, K., Vasquez, D. M., Silvas, J., Park, J.-G., Piepenbrink, M., Sourimant, J., Lin, M. J., Greninger, A. L., Plemper, R. K., Torrelles, J. B., Walter, M. R., de la Torre, J. C., Kobie, J., Martinez-Sobrido, L.
10.1101/2021.06.28.450214 — Posted: 2021-06-28
Enhanced fitness of SARS-CoV-2 variant of concern B.1.1.7, but not B.1.351, in animal models
Ulrich, L., Halwe, N. J., Taddeo, A., Ebert, N., Schön, J., Devisme, C., Trüeb, B. S., Hoffmann, B., Wider, M., Bekliz, M., Essaidi-Laziosi, M., Schmidt, M. L., Niemeyer, D., Corman, V. M., Kraft, A., Godel, A., Laloli, L., Kelly, J. N., Breithaupt, A., Wylezich, C., Berenguer Veiga, I. M., Gultom, M., Adea, K., Meyer, B., Eberhardt, C., Thomann, L., Gsell-Albert, M., Labroussaa, F., Jores, J., Summerfield, A., Drosten, C., Eckerle, I. A., Dijkman, R., Hoffmann, D., Thiel, V., Beer, M., Benarafa, C.
10.1101/2021.06.28.450190 — Posted: 2021-06-28
SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: everybody does their best
Fernandez Salinas, A., Piano Mortari, E., Terreri, S., Quintarelli, C., Pulvirenti, F., Di Cecca, S., Guercio, M., Milito, C., Bonanni, L., Auria, S., Romaggioli, L., Cusano, G., Albano, C., Zaffina, S., Perno, C. F., Spadaro, G., Locatelli, F., Carsetti, R., Quinti, I.
10.1101/2021.06.24.21259130 — Posted: 2021-06-28
N4-hydroxycytidine and inhibitors of dihydroorotate dehydrogenase synergistically suppress SARS-CoV-2 replication
Stegmann, K. M., Dickmanns, A., Heinen, N., Gross, U., Goerlich, D., Pfaender, S., Dobbelstein, M.
10.1101/2021.06.28.450163 — Posted: 2021-06-28
Solar simulated ultraviolet radiation inactivates HCoV-NL63 and SARS-CoV-2 coronaviruses at environmentally relevant doses
Wondrak, G. T., Jandova, J., Williams, S. J., Schenten, D.
10.1101/2021.06.25.449831 — Posted: 2021-06-28
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
Choi, A., Koch, M., Wu, K., Dixon, G., Oestreicher, J., Legault, H., Stewart-Jones, G. B. E., Colpitts, T., Pajon, R., Bennett, H., Carfi, A., Edwards, D. K.
10.1101/2021.06.28.449914 — Posted: 2021-06-28
Effect of prophylactic use of intra-nasal oil formulations in the hamster model of Covid-19
Rizvi, Z. A., Tripathy, M. R., Sharma, N., Goswami, S., Srikanth, N., Shastry, J., Mani, S., Surjit, M., Awasthi, A., Dikshit, M.
10.1101/2021.06.25.449990 — Posted: 2021-06-28
A SARS-CoV-2 mini-genome assay based on negative-sense RNA to study replication inhibitors and emerging mutations
Vial, T., Oade, M. S., Russell, C. A., Eggink, D., te Velthuis, A. J. W.
10.1101/2021.06.28.450211 — Posted: 2021-06-28
Myeloid cell interferon responses correlate with clearance of SARS-CoV-2
Singh, D. K., Aladyeva, E., Das, S., Singh, B., Esaulova, E., Swain, A., Ahmed, M., Cole, J., Moodley, C., Mehra, S., Schlesinger, L., Artyomov, M., Khader, S. A., Kaushal, D.
10.1101/2021.06.28.450153 — Posted: 2021-06-28
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2
Jiang, L., Driedonks, T., Lowman, M., Jong, W. S., van den Berg van Saparoea, H. B., Dhakal, S., Zhou, R., Caputo, C., Littlefield, K., Sitaris, I., Chen, M. W., Lima, G., Gololobova, O., Smith, B., Lane, A. P., Klein, S. L., Pekosz, A., Brayton, C. F., Luirink, J., Villano, J. S., Witwer, K. W.
10.1101/2021.06.28.450181 — Posted: 2021-06-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).